SAN DIEGO, Aug. 2 /PRNewswire-FirstCall/ -- Gen-Probe
Incorporated (Nasdaq: GPRO) announced today that the Company will
present at the Leerink Swann Life Science Tools and Diagnostics
Roundtable Conference on Thursday, August 5,
2010 at approximately 12:50 p.m.
Eastern time. The presentation is scheduled to be webcast
live and may be accessed through a link on the investors section of
Gen-Probe's website at www.gen-probe.com. The webcast will be
available for 30 days following the event.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development,
manufacture and marketing of rapid, accurate and cost-effective
molecular diagnostic products and services that are used primarily
to diagnose human diseases, screen donated human blood, and ensure
transplant compatibility. Gen-Probe has approximately 27
years of expertise in nucleic acid testing (NAT), and received the
2004 National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs approximately 1,300
people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations,
beliefs, plans, objectives, assumptions or future events or
performance are not historical facts and are forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results to differ materially
from those expressed or implied. For information about risks
and uncertainties we face and a discussion of our financial
statements and footnotes, see documents we have filed with the SEC,
including our most recent Form 10-K, and all subsequent periodic
filings. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events.
Contact:
|
|
|
|
Paula Izidoro
|
|
Investor Relations
|
|
858-410-8904
|
|
|
SOURCE Gen-Probe Incorporated
Copyright g. 2 PR Newswire